MUC16 and AL amyloidosis: Li et al. suggest that CA125 may be non-inferior to NT-proBNP, troponin, and LDH in predicting outcomes in light-chain amyloidosis, while Wu et al. linked CA125 with cardiorenal amyloidosis progression [87,88].